The invention relates to organophosphorus compounds of general formula (I) wherein A corresponds to general formula (II), wherein one or more of the carbon atoms, selected from the group C.sub.3, C.sub.4, C.sub.5 and their respective substituents can be omitted, and at least one substituent of B.sub.1 to B.sub.10 is a C.sub.3-8 cycloalkyl (C.sub.0-9) alkyl group, wherein both the C.sub.3-8 cycloalkyl group and the C.sub.0-9 alkyl group can have one or more double bonds and one or two carbon atoms of the cycloalkyl group can be substituted by nitrogen, oxygen or sulfur atoms, and wherein both the cycloalkyl group and the alkyl group can be substituted by hydrogen, halogen amine, oxo groups with branched or unbranched C.sub.1-9 alkyl groups and C.sub.2-9 alkenyl groups, wherein the C.sub.1-9 alkyl groups and C.sub.2-9 alkenyl groups can be substituted by hydrogen, hydroxy, amine, halogen, and oxo groups. The invention further relates to pharmaceutical preparations containing said compounds and to the use thereof for the therapy and prophylaxis of infectious processes in humans and animals, which processes are induced by bacteria, fungi or parasites. The inventive compounds are also used as fungicidal, bactericidal or herbicidal agents in plants.
CROSS REFERENCE TO RELATED APPLICATIONS
Applicant claims priority under 35 U.S.C. .sctn.119 of German Application No. 198 54 403.0 filed Nov. 25, 1998. Applicant also claims priority under 35 U.S.C. .sctn.120 of PCT/EP99/08966 filed Nov. 20, 1999. The international application under PCT article 21(2) was not published in English.
